Foreign Cash Repatriation Bill Can Pass If Tied To Jobs, Breaux Tells PhRMA
This article was originally published in The Tan Sheet
Executive Summary
Legislation to allow pharmaceutical companies to transfer cash held by overseas affiliates to the U.S. has a chance to pass Congress this year - if the bill ensures that proceeds are devoted to the creation of new jobs, Sen. John Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting April 3 in Palm Beach, Fla
You may also be interested in...
Rx Firms Feeling Re-Patriotic As Foreign Tax Bill Moves Through Congress
Supporters of a tax change that would allow U.S. pharmaceutical companies to "repatriate" cash held by overseas affiliates appear confident that the proposal will be enacted into law this year
Rx Firms Feeling Re-Patriotic As Foreign Tax Bill Moves Through Congress
Supporters of a tax change that would allow U.S. pharmaceutical companies to "repatriate" cash held by overseas affiliates appear confident that the proposal will be enacted into law this year
Abbott Sees Opportunity In Foreign Income Repatriation Bill
Legislation pending in Congress to allow repatriation of overseas income is an "interesting opportunity," Abbott Chief Financial Officer Thomas Freyman said during an Oct. 9 conference call